Answered on the record on 30 October 2026, from the files as they stood that day Falling
Intercure falls furthest of the drugmakers in the record, its three tenses running from 6.6 in the past to 1.8 in the future, followed by Zoetis, from 8.4 to 4.4. The ten below lead the part of the family's 497 graded drugmakers whose tenses fall end to end, among those with more than three metrics read as filed.
How this list was made. By the screener's direction rule, a company falls when its tenses never rise from past to present to future and its future is more than half a point below its past. The tenses come from the family report of 29 October 2026 for Pharmaceutical Preparations, industry code 2834; only companies with more than three of the nine metrics read as filed count. The ten that fall furthest are listed, ties by headline, highest first; a falling arc is the record's reading of the company, never a price or a move.
- INCRIntercure Ltd. past 6.6, present 5.3, future 1.8Its three tenses fall end to end, from 6.6 in the past to 1.8 in the future. The headline is 4.7 of 10, with 7 of the nine metrics read as filed and 2 CrossAssetData estimates.
- ZTSZoetis Inc. past 8.4, present 7.0, future 4.4Its three tenses fall end to end, from 8.4 in the past to 4.4 in the future. The headline is 6.7 of 10, with all nine metrics read as filed.
- AMPHAmphastar Pharmaceuticals, Inc. past 7.8, present 7.4, future 4.1Its three tenses fall end to end, from 7.8 in the past to 4.1 in the future. The headline is 6.5 of 10, with all nine metrics read as filed.
- JAZZJazz Pharmaceuticals plc past 8.0, present 6.5, future 4.3Its three tenses fall end to end, from 8.0 in the past to 4.3 in the future. The headline is 6.3 of 10, with all nine metrics read as filed.
- TAKTakeda Pharmaceutical Company Limited past 7.9, present 4.9, future 4.4Its three tenses fall end to end, from 7.9 in the past to 4.4 in the future. The headline is 5.7 of 10, with 8 of the nine metrics read as filed and 1 CrossAssetData estimate.
- EVOEvotec SE past 6.5, present 5.6, future 3.0Its three tenses fall end to end, from 6.5 in the past to 3.0 in the future. The headline is 5.1 of 10, with 8 of the nine metrics read as filed and 1 CrossAssetData estimate.
- PRTAProthena Corporation plc past 6.7, present 5.9, future 3.2Its three tenses fall end to end, from 6.7 in the past to 3.2 in the future. The headline is 5.0 of 10, with 8 of the nine metrics read as filed and 1 CrossAssetData estimate.
- OMEROmeros Corporation past 6.2, present 5.8, future 2.7Its three tenses fall end to end, from 6.2 in the past to 2.7 in the future. The headline is 4.6 of 10, with 7 of the nine metrics read as filed and 2 CrossAssetData estimates.
- ABBVAbbvie Inc. past 8.0, present 6.1, future 4.6Its three tenses fall end to end, from 8.0 in the past to 4.6 in the future. The headline is 6.3 of 10, with all nine metrics read as filed.
- PAHCPhibro Animal Health Corporation past 8.0, present 6.4, future 4.7Its three tenses fall end to end, from 8.0 in the past to 4.7 in the future. The headline is 6.4 of 10, with all nine metrics read as filed.
Left out as thin
Two companies with thin records fall further than the list's last row: Novartis AG, from 6.9 to 3.2, and Sanofi, from 6.7 to 3.2. Each has only 3 of the nine metrics read as filed, so the report marks both thin and the list leaves them out.
By the desk, an AI model, from the record alone (ruling 162). Every figure is a field of the files named above, matched by value when the answer was staged. Nothing here is advice, and nothing here is a price.
Ask your own question → Every answer